| |
| |
| Exchange: |
New York Stock Exchange |
| Security
Type: |
Common |
| Shares
Out: |
355,150,000 |
| Market
Cap: |
2.26(B) |
| Last
Volume: |
17,273,575 |
Avg
Vol: |
17,226,033 |
| 52
Week Range: |
$6.53 - $10.61 |
|
| Level
I Sector: |
Health Care |
| Level
II Sector: |
Drugs |
| Level
III Sector: |
Biotechnology |
|
Member Indexes:
|
| |
S&P COMPOSITE 1500 |
|
NYSE COMPOSITE |
| |
S&P 400 MIDCAP |
|
Rankings:
|
|
| Insider 3 Months : - |
| Insider 6 Months : - |
| Insider 3/6 Months : - |
|
| Guru Rank Number : - |
| Guru Rank Value : - |
| Guru Occurances : - |
|
|
|
|
|
| |
|
Company Profile Bausch Health Companies develops, manufactures and markets, primarily in the therapeutic areas of eye-health, gastroenterology and dermatology, a range of: pharmaceuticals, generic and branded generic pharmaceuticals, over-the-counter (OTC) products and medical devices (contact lenses, intraocular lenses, ophthalmic surgical equipment and aesthetics devices). Co.'s portfolio of products falls into four operating and reportable segments: Bausch + Lomb/International, Salix, Ortho Dermatologics and Diversified Products.
|
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
|
3m +/-:
|
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
|
Actions:
|
|
|
| B |
Buy |
| S |
Sell |
| OE |
Option
Exercised |
| A |
Acquired |
| D |
Disposed |
| AB |
Automatic
Buy |
| AS |
Automatic
Sell |
| IO |
Initial
Ownership |
|
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
| |
| |
Summary (Direct Transactions Only)  |
3 Months |
6 Months |
12 Months |
24 Months |
| Total Shares Bought |
0 |
0 |
0 |
0 |
| Total Buy Value |
$0 |
$0 |
$0 |
$0 |
| Total People Bought |
0 |
0 |
0 |
0 |
| Total Buy Transactions |
0 |
0 |
0 |
0 |
| Total Shares Sold |
6,313 |
6,533 |
13,261 |
14,828 |
| Total Sell Value |
$61,867 |
$63,491 |
$119,170 |
$133,715 |
| Total People Sold |
1 |
1 |
1 |
1 |
| Total Sell Transactions |
1 |
2 |
4 |
7 |
| End Date |
2024-02-22 |
2023-11-21 |
2023-05-23 |
2022-05-23 |
|
| Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
  De Schutter Richard U |
Director |
• • – |
2020-09-30 |
4 |
A |
$15.54 |
$33,737 |
D/D |
2,171 |
295,600 |
|
- |
|
| Wechsler Amy B |
Director |
• • – |
2020-09-30 |
4 |
A |
$15.54 |
$6,869 |
D/D |
442 |
101,171 |
|
- |
|
| Papa Joseph C |
CHAIRMAN & CEO |
• • – |
2020-09-15 |
4 |
D |
$15.91 |
$81,380 |
D/D |
(5,115) |
799,865 |
|
- |
|
| Herendeen Paul |
EVP and CFO |
• • – |
2020-09-15 |
4 |
D |
$15.91 |
$26,124 |
D/D |
(1,642) |
298,611 |
|
- |
|
| Papa Joseph C |
CHAIRMAN & CEO |
• • – |
2020-09-14 |
4 |
D |
$15.40 |
$55,794 |
D/D |
(3,623) |
804,980 |
|
- |
|
| Humphries William D. |
President, Ortho-Dermatologics |
• • – |
2020-09-08 |
4 |
AS |
$16.17 |
$91,635 |
D/D |
(5,667) |
235,035 |
|
67% |
|
| Ackermann Christina |
EVP AND GENERAL COUNSEL |
• • – |
2020-08-28 |
4 |
A |
$0.00 |
$0 |
D/D |
28,171 |
124,196 |
|
- |
|
| Spurr Robert |
President, Salix |
• • – |
2020-08-28 |
4 |
D |
$17.00 |
$21,726 |
D/D |
(1,278) |
38,972 |
|
- |
|
| Humphries William D. |
President, Ortho-Dermatologics |
• • – |
2020-08-17 |
4 |
D |
$17.48 |
$79,831 |
D/D |
(4,567) |
240,702 |
|
- |
|
| De Schutter Richard U |
Director |
• • – |
2020-06-30 |
4 |
A |
$18.29 |
$32,008 |
D/D |
1,750 |
293,429 |
|
- |
|
| Robertson Russel C |
Director |
• • – |
2020-06-30 |
4 |
A |
$18.29 |
$37,495 |
D/D |
2,050 |
109,489 |
|
- |
|
| Paulson John |
Director |
• • – |
2020-06-30 |
4 |
A |
$18.29 |
$28,258 |
D/D |
1,545 |
70,068 |
|
- |
|
| Wechsler Amy B |
Director |
• • – |
2020-06-30 |
4 |
A |
$18.29 |
$6,859 |
D/D |
375 |
100,729 |
|
- |
|
| Valueact Holdings Gp, Llc |
See Remarks |
– • – |
2020-06-05 |
4 |
B |
$19.24 |
$18,246,312 |
I/I |
948,353 |
17,931,594 |
2.1 |
-11% |
|
| Valueact Holdings Gp, Llc |
See Remarks |
– • – |
2020-06-05 |
4 |
S |
$19.24 |
$18,246,312 |
I/I |
(948,353) |
0 |
|
11% |
|
| Spurr Robert |
President, SalixOfficer |
• – – |
2020-05-27 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
40,250 |
|
-11% |
|
| Paulson John |
|
• • – |
2020-05-14 |
4 |
B |
$15.65 |
$25,857,837 |
I/I |
1,628,920 |
25,839,035 |
0.01 |
-7% |
|
| Paulson John |
|
• • – |
2020-05-13 |
4 |
B |
$16.32 |
$21,972,617 |
I/I |
1,330,044 |
24,210,115 |
0.01 |
-4% |
|
| Paulson John |
|
• • – |
2020-05-12 |
4 |
B |
$17.24 |
$35,421,082 |
I/I |
2,041,036 |
22,880,071 |
0.01 |
-5% |
|
| Papa Joseph C |
CHAIRMAN & CEO |
• • – |
2020-05-04 |
4 |
D |
$17.16 |
$1,638,591 |
D/D |
(95,489) |
808,603 |
|
- |
|
| Power Robert N |
Director |
• • – |
2020-05-01 |
4 |
A |
$0.00 |
$0 |
D/D |
11,037 |
93,779 |
|
- |
|
| Karabelas Argeris N |
Director |
• • – |
2020-05-01 |
4 |
A |
$0.00 |
$0 |
D/D |
11,037 |
81,683 |
|
- |
|
| Kavanagh Sarah B |
Director |
• • – |
2020-05-01 |
4 |
A |
$0.00 |
$0 |
D/D |
11,037 |
75,415 |
|
- |
|
| Wechsler Amy B |
Director |
• • – |
2020-05-01 |
4 |
A |
$0.00 |
$0 |
D/D |
11,037 |
100,354 |
|
- |
|
| Robertson Russel C |
Director |
• • – |
2020-05-01 |
4 |
A |
$0.00 |
$0 |
D/D |
11,037 |
107,439 |
|
- |
|
705 Records found
|
|
Page 11 of 29 |
|
|
0.18 (2.75%) 
